Most not too long ago, it has been identified that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some wide array of endogenous opioids. As opposed to most opioid receptors, this receptor https://johnw283aqh4.theideasblog.com/profile